Assessing the Risk of Myocarditis Post-COVID-19 Vaccination: A Systematic Review of Case Reports from 2023 to 2025 [0.03%]
评估新冠疫苗接种后心肌炎风险：2023至2025年病例报告的系统回顾
Alessio Ardizzone,Charlaine A Agoy,Giuseppe Carota et al.
Alessio Ardizzone et al.
Inhalant Exposures and the Risk of Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease [0.03%]
吸入性暴露与类风湿关节炎和类风湿关节炎相关间质性肺病的风险关系
Spencer Jones,Ted R Mikuls,Bryant R England
Spencer Jones
Sex-Specific Associations Between Cadmium Exposure and Mortality Risk in Cardiovascular Disease Patients: A Cohort Study Integrating Molecular Mechanisms of Myocardial Dysfunction [0.03%]
镉暴露与心血管疾病患者性别特异性死亡风险关联的前瞻性队列研究：整合分子机制的心肌功能障碍研究
Caili He,Kaiwen Wang,Ruiqi Yang et al.
Caili He et al.
Targeting the Apelin-APJ Axis: A Promising Strategy to Mitigate Anthracycline-Induced Cardiotoxicity [0.03%]
靶向阿普林-APJ轴：防治蒽环类药物诱发的心脏毒性的新策略
Varsha G Desai
Varsha G Desai
Anthracycline-induced cardiotoxicity remains a major clinical challenge, often progressing to heart failure years after therapy. Conventional cardioprotective agents, including angiotensin-converting enzyme inhibitors, angiotensin receptor ...
Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor [0.03%]
微塑料和纳米塑料与心血管病：一种新兴的心血管危险因素
Alberto Polimeni,Domenico Simone Castiello,Rossella Quarta et al.
Alberto Polimeni et al.
Microplastics and nanoplastics (MNPs) have become pervasive contaminants in air, water, and food, leading to continuous human exposure. Contrary to the long-standing assumption that these particles are biologically inert, accumulating evide...
Cardiovascular Health and Fluoride Toxicity: A Qualitative Systematic Review [0.03%]
心血管健康与氟中毒：定性系统评价研究报告
Rashi Baltoo,Ruhi Thakur,Srishti Rana
Rashi Baltoo
A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement [0.03%]
基于FAERS数据库和美国心脏协会声明的药物诱发心力衰竭 disproportion分析研究
Da Li,Yidan Dong,Lei Yao et al.
Da Li et al.
Heart failure (HF), the advanced stage of diverse cardiac conditions, poses a significant public health challenge. This study analyzes adverse event (AE) signals associated with HF within the FDA Adverse Event Reporting System (FAERS) datab...
Zebrafish Model Reveals Early Electrocardiographic and Molecular Signatures of Doxorubicin-Induced Cardiotoxicity [0.03%]
斑马鱼模型揭示了多柔比星诱导的心脏毒性的早期心电图和分子特征
Zih-Yin Lai,Chi-Ying Lee,Yu-Ching Chiu et al.
Zih-Yin Lai et al.
Doxorubicin (DOX) is a highly effective anthracycline widely used in cancer therapy but limited by its dose-dependent cardiotoxicity, which may result in arrhythmia, dilated cardiomyopathy, and heart failure. Conventional surveillance tools...
Hydroxysafflor Yellow A Attenuates Sepsis-Induced Cardiac Dysfunction by Inhibiting Ferroptosis via Activation of Thioredoxin [0.03%]
通过激活硫氧还蛋白抑制铁死亡羟基红花黄色素A可减轻脓毒症诱导的心脏功能障碍
Yanke Chen,Xu Cai,Wenbin Nan et al.
Yanke Chen et al.
Ferroptosis is increasingly recognized as a key driver of sepsis-induced cardiac dysfunction. Hydroxysafflor yellow A (HSYA), a bioactive flavonoid, shows cardioprotective properties, but its role in ferroptosis remains unclear. Network pha...
Large-Scale Signal Detection and Personalized Risk Prediction for Cardiovascular Drug Adverse Reactions in Elderly Patients: Real-World Evidence from Western China [0.03%]
基于中国西部真实世界证据的大规模心血管药物不良反应信号检测与个体化风险预测研究
Zimeng Li,Shuzhi Lin,Yifang Shen et al.
Zimeng Li et al.